These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cutaneous reactions to drugs used for rheumatologic disorders. Roth DE, Spencer LV, Ahrens EM. Med Clin North Am; 1989 Sep; 73(5):1275-98. PubMed ID: 2671546 [Abstract] [Full Text] [Related]
25. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study. Cox NH, Jones SK, Downey DJ, Tuyp EJ, Jay JL, Moseley H, Mackie RM. Br J Dermatol; 1987 Feb; 116(2):145-52. PubMed ID: 3828211 [Abstract] [Full Text] [Related]
26. [Chloroquine and hydroxychloroquine: side effect profile of important therapeutic drugs]. Ochsendorf FR, Runne U. Hautarzt; 1991 Mar; 42(3):140-6. PubMed ID: 2055762 [Abstract] [Full Text] [Related]
27. Toxicity and monitoring of immunosuppressive therapy used in systemic autoimmune diseases. Meyer KC, Decker C, Baughman R. Clin Chest Med; 2010 Sep; 31(3):565-88. PubMed ID: 20692548 [Abstract] [Full Text] [Related]
28. Antimalarials for children: indications, toxicities, and guidelines. Ziering CL, Rabinowitz LG, Esterly NB. J Am Acad Dermatol; 1993 May; 28(5 Pt 1):764-70. PubMed ID: 8496422 [Abstract] [Full Text] [Related]
29. Comparative tolerability of systemic treatments for plaque-type psoriasis. McClure SL, Valentine J, Gordon KB. Drug Saf; 2002 May; 25(13):913-27. PubMed ID: 12381213 [Abstract] [Full Text] [Related]
31. Cutaneous and ocular ramifications of ultraviolet radiation. Lerman S, Van Voorhees A. Dermatol Clin; 1992 Jul; 10(3):483-504. PubMed ID: 1617808 [Abstract] [Full Text] [Related]
32. Ocular effects of oral retinoids. Lebowitz MA, Berson DS. J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):209-11. PubMed ID: 3045165 [Abstract] [Full Text] [Related]
33. [Ocular changes in rheumatoid arthritis]. Siliato F, Scarsi MR, Bonioli E, Patrone P, Cambiaso R, Gemme G. Minerva Pediatr; 1978 Nov 30; 30(22):1761-6. PubMed ID: 569251 [No Abstract] [Full Text] [Related]
34. The prevention of drug-induced retinopathies. Crews SJ. Trans Ophthalmol Soc U K (1962); 1966 Nov 30; 86():63-76. PubMed ID: 5335103 [No Abstract] [Full Text] [Related]
35. [Effect of drugs on the eye]. Jaros Z. Cas Lek Cesk; 1970 Mar 06; 109(11):253-5. PubMed ID: 4914615 [No Abstract] [Full Text] [Related]
36. A new look at the ocular side-effects of long-term systemic corticosteroid and adrenocorticotrophic therapy. Williamson J. Proc R Soc Med; 1970 Aug 06; 63(8):791-2. PubMed ID: 4318041 [No Abstract] [Full Text] [Related]
37. [Complications with synthetic antimalarials]. Huriez C, Desmons F, Gautier G, Dhellemmes. Lille Med; 1969 Oct 06; 14(8):851-64. PubMed ID: 4251585 [No Abstract] [Full Text] [Related]
38. [Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average]. Bertrand JJ, Debeyre N, Kahn MF, Ryckewaert A. Presse Med (1893); 1968 Nov 23; 76(45):2139-42. PubMed ID: 5720115 [No Abstract] [Full Text] [Related]
39. Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine. Laaksonen AL, Koskiahde V, Juva K. Scand J Rheumatol; 1974 Nov 23; 3(2):103-8. PubMed ID: 4608161 [No Abstract] [Full Text] [Related]
40. Ocular toxicity of antimalarial drugs. Long-term follow-up. Carr RE, Henkind P, Rothfield N, Siegel IM. Am J Ophthalmol; 1968 Oct 23; 66(4):738-44. PubMed ID: 5729592 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]